Maria Whatton

Maria Whatton is an accomplished Principal Scientist specializing in computational drug discovery at Evotec since September 2020, leading early-phase projects within the Molecular Architect department. Prior to this, Maria held various roles at Eli Lilly and Company, including Senior Research Scientist, where leadership of cross-functional teams resulted in pivotal scaffold recommendations and novel small molecule designs. With a solid foundation in medicinal chemistry and computational techniques, Maria has consistently applied innovative approaches in drug design, contributing to multiple patent publications. Educational qualifications include a Ph.D. and a Bachelor's Degree in Chemistry from Cardiff University, complemented by strong academic performance in earlier studies.